Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
인터루킨-18의 예후 가치와 코로나19의 다른 염증 표지자 및 질병 중증도와의 연관성
Article
[키워드] Admission
age and sex
analyzed
antagonist
antagonists
approach
association
Asymptomatic
biochemical marker
biochemical markers
blood sample
Blood samples
Care
Characteristics
Clinical characteristics
clinical trial
clinical trials
collected
Concentration
consequence
control group
correlated
COVID-19
COVID-19 pathogenesis
COVID-19 patient
COVID-19 patients
creatinine
CRP
cut off value
cytokine
Cytokines
D-dimer
death
defined
demographic and clinical characteristics
determined by
detrimental
Diagnosis
died
dimer
disease
disease severity
ELISA
enrolled
Enrollment
Evidence
feature
ferritin
healthy subject
healthy subjects
highest
hospital discharge
ICU
ICU admission
IL-18
IL-6
immune response
increased risk
individual
Inflammatory marker
inflammatory markers
intensive care
intensive care unit
interleukin
Interleukin-18
Laboratory
lead
liver enzyme
liver enzymes
Macrophage
macrophage activation syndrome
male
median age
Mild
mild pneumonia
nine
nucleic acid
on admission
organ
organ injury
outcome
Patient
Pneumonia
procalcitonin
Prognosis
radiological
required
Result
RT-PCR
SARS-CoV-2 nucleic acid
serum
serum concentrations
Serum level
serum levels
severe COVID-19 patients
severe group
severe pneumonia
study population
three group
three groups
Treatment
troponin
Viral
viral infections
were measured
with COVID-19
[DOI] 10.1016/j.cyto.2020.155302 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cyto.2020.155302 PMC 바로가기 [Article Type] Article